OneDigital Investment Advisors LLC acquired a new stake in Novanta Inc. (NASDAQ:NOVT – Free Report) in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 5,836 shares of the technology company’s stock, valued at approximately $947,000.
Other large investors have also recently made changes to their positions in the company. AQR Capital Management LLC boosted its holdings in shares of Novanta by 78.9% in the 1st quarter. AQR Capital Management LLC now owns 4,231 shares of the technology company’s stock worth $537,000 after buying an additional 1,866 shares during the last quarter. Goldman Sachs Group Inc. grew its position in Novanta by 1.6% during the first quarter. Goldman Sachs Group Inc. now owns 419,037 shares of the technology company’s stock valued at $53,582,000 after buying an additional 6,533 shares during the period. Jane Street Group LLC increased its holdings in Novanta by 1,762.5% during the first quarter. Jane Street Group LLC now owns 61,631 shares of the technology company’s stock worth $7,881,000 after buying an additional 58,322 shares during the last quarter. First Trust Advisors LP purchased a new stake in Novanta during the second quarter worth about $528,000. Finally, Amundi raised its position in Novanta by 2.0% in the second quarter. Amundi now owns 18,042 shares of the technology company’s stock worth $2,397,000 after acquiring an additional 347 shares during the period. 98.35% of the stock is owned by hedge funds and other institutional investors.
Novanta Price Performance
NOVT opened at $168.75 on Tuesday. The company has a market capitalization of $6.38 billion, a price-to-earnings ratio of 108.17 and a beta of 1.68. The company has a quick ratio of 3.79, a current ratio of 4.57 and a debt-to-equity ratio of 0.12. The firm has a 50-day moving average price of $154.41 and a 200-day moving average price of $142.88. Novanta Inc. has a twelve month low of $98.27 and a twelve month high of $176.38.
Insider Activity
In other Novanta news, CEO Matthijs Glastra sold 6,500 shares of the stock in a transaction on Thursday, July 2nd. The stock was sold at an average price of $161.13, for a total transaction of $1,047,345.00. Following the sale, the chief executive officer owned 29,761 shares in the company, valued at $4,795,389.93. This represents a 17.93% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.20% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
NOVT has been the topic of a number of research analyst reports. Weiss Ratings reiterated a “hold (c-)” rating on shares of Novanta in a research note on Wednesday, July 15th. Robert W. Baird set a $194.00 price target on shares of Novanta in a report on Friday, August 7th. Finally, Wall Street Zen upgraded Novanta from a “hold” rating to a “buy” rating in a research note on Sunday, August 9th. One equities research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $194.00.
Check Out Our Latest Analysis on NOVT
Novanta Company Profile
Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.
Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.
Featured Stories
- Five stocks we like better than Novanta
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT – Free Report).
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.
